sb-1518 and Neoplasms

sb-1518 has been researched along with Neoplasms* in 1 studies

Other Studies

1 other study(ies) available for sb-1518 and Neoplasms

ArticleYear
Discovery of 4-piperazinyl-2-aminopyrimidine derivatives as dual inhibitors of JAK2 and FLT3.
    European journal of medicinal chemistry, 2019, Nov-01, Volume: 181

    Topics: Apoptosis; Cell Line, Tumor; Cell Proliferation; Drug Design; fms-Like Tyrosine Kinase 3; Humans; Janus Kinase 2; Molecular Docking Simulation; Neoplasms; Piperazines; Protein Kinase Inhibitors; Pyrimidines

2019